Intraperitoneal therapy of ovarian cancer with retargeted lymphocytes by bispecific monoclonal antibodies and interleukin-2-Reference-Cited by-同舟云学术

Intraperitoneal therapy of ovarian cancer with retargeted lymphocytes by bispecific monoclonal antibodies and interleukin-2

Published:1995-03 Issue:2 Volume:27 Page:90-92
ISSN:0001-544X
Container-title:European Surgery
language:en
Short-container-title:Acta Chir Austriaca

Author:

Eggermont A. M. M.,Goey S. H.,Logmans A.,Trimbos J. B. M. Z.,Warnaar S. O.,Cleton F. J.,Lamers C. H. J.,Bolhuis R. L. H.,Stoter G.

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/BF02602251.pdf

Reference22 articles.

1. Bolhuis RLH, Roozemond RC, Van de Griend RJ: Induction and blocking of cytolysis in CD2+CD3− NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor. J Immunol 1986; 136:3939–3944.

2. Burg MEL van der, Hoff AM, van Lent M, Rodenburg CJ, van Putten WLJ, Stoter G: Carboplatin and cyclophosphamide salvage therapy for ovarian cancer patients relapsing after cisplatin combination therapy. Eur. J Cancer 1991;27:248–250.

3. Colnaghi MI, Buraggi GL, Canevari S, di Re F, Leoni F, Mangioni C, Menard S, Orlandi R. Evaluation of the suitability of a monoclonal antibody raised against human ovarian carcinoma for therapeutic approaches. Nucl Med Biol 1989;16:633–636.

4. Dijk J van, Warnaar SO, Van Eendenburg JDH, Boot JHA, Thienponmt M, Fleuren GJ, Bolhuis RLH: Induction of tumor cell lysis by bispecific monoclonal antibodies recognizing renal cell carcinoma and CD3 antigen. Int J Cancer 1989;43:344–349.

5. Eggernont AMM: Intracavitary immunotherapy. Reg Cancer Treat 1989;2:37–48.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial;European Surgery;1995-03